Nebivolol, carvedilol and metoprolol do not influence cardiac Ca(2+) sensitivity
It has been argued that some beta-adrenoceptor antagonists may directly influence myofibrillar cross-bridge interaction in cardiac skinned fiber preparations of animal models. The present study investigates the effects of nebivolol, metoprolol and carvedilol on tension development of Triton X-100 sk...
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 2001-06, Vol.422 (1-3), p.175-180 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 180 |
---|---|
container_issue | 1-3 |
container_start_page | 175 |
container_title | European journal of pharmacology |
container_volume | 422 |
creator | Bundkirchen, A Brixius, K Bölck, B Mehlhorn, U Bloch, W Schwinger, R H |
description | It has been argued that some beta-adrenoceptor antagonists may directly influence myofibrillar cross-bridge interaction in cardiac skinned fiber preparations of animal models. The present study investigates the effects of nebivolol, metoprolol and carvedilol on tension development of Triton X-100 skinned fibers obtained from human failing myocardium as well as on force of contraction and intracellular Ca(2+) transient in isolated trabeculae. In skinned fiber preparations, none of the beta-adrenoceptor antagonists (10 microM) influenced Ca(2+) sensitivity of tension development or maximal Ca(2+) activated tension (DT(max)): control: EC(50) for Ca(2+): 1.28+/-0.05 microM, DT(max): 14.09+/-0.59 mN/mm(2); nebivolol: 1.36+/-0.1 microM, 14.14+/-0.95 mN/mm(2); carvedilol: 1.32+/-0.11 microM, 13.83+/-0.90 mN/mm(2); metoprolol: 1.34+/-0.14 microM, 13.72+/-0.36 mN/mm(2). Simultaneous measurement of force and Ca(2+) transient in the presence of the beta-adrenoceptor antagonists (3 microM) showed that the decrease in force of contraction was paralleled by a similar decrease in the intracellular Ca(2+) transient. In conclusion, none of the investigated beta-adrenoceptor antagonists influenced Ca(2+) sensitivity of myofibrillar tension development in human failing myocardium. |
doi_str_mv | 10.1016/S0014-2999(01)01082-2 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71005471</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71005471</sourcerecordid><originalsourceid>FETCH-LOGICAL-p122t-d00bc9fd3663dd11f6daeb007c7323df7ea59ea9298bdd539ecd2490cbbf53233</originalsourceid><addsrcrecordid>eNo9kFtLAzEQhfOg2Fr9CUqepEVXJ8lemseyeIOigvq8JJlZiOylbnYL_fdusfp0DnM-hpnD2IWAWwEivXsHEHEktdZzEAsQsJSRPGLT__GEnYbwBQCJlskJmwgRK9ByOWVvL2T9tq3a6oY7020J_ei5aZDX1Lebbh9xbHnT9tw3ZTVQ42iPojeO52Yurxc8UBN877e-352x49JUgc4POmOfD_cf-VO0fn18zlfraCOk7CMEsE6XqNJUIQpRpmjIAmQuU1JhmZFJNBkt9dIiJkqTQxlrcNaWyUioGbv63Tue-D1Q6IvaB0dVZRpqh1BkYvw2zsQIXh7AwdaExabztel2xV8H6gfhCV2N</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71005471</pqid></control><display><type>article</type><title>Nebivolol, carvedilol and metoprolol do not influence cardiac Ca(2+) sensitivity</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Bundkirchen, A ; Brixius, K ; Bölck, B ; Mehlhorn, U ; Bloch, W ; Schwinger, R H</creator><creatorcontrib>Bundkirchen, A ; Brixius, K ; Bölck, B ; Mehlhorn, U ; Bloch, W ; Schwinger, R H</creatorcontrib><description>It has been argued that some beta-adrenoceptor antagonists may directly influence myofibrillar cross-bridge interaction in cardiac skinned fiber preparations of animal models. The present study investigates the effects of nebivolol, metoprolol and carvedilol on tension development of Triton X-100 skinned fibers obtained from human failing myocardium as well as on force of contraction and intracellular Ca(2+) transient in isolated trabeculae. In skinned fiber preparations, none of the beta-adrenoceptor antagonists (10 microM) influenced Ca(2+) sensitivity of tension development or maximal Ca(2+) activated tension (DT(max)): control: EC(50) for Ca(2+): 1.28+/-0.05 microM, DT(max): 14.09+/-0.59 mN/mm(2); nebivolol: 1.36+/-0.1 microM, 14.14+/-0.95 mN/mm(2); carvedilol: 1.32+/-0.11 microM, 13.83+/-0.90 mN/mm(2); metoprolol: 1.34+/-0.14 microM, 13.72+/-0.36 mN/mm(2). Simultaneous measurement of force and Ca(2+) transient in the presence of the beta-adrenoceptor antagonists (3 microM) showed that the decrease in force of contraction was paralleled by a similar decrease in the intracellular Ca(2+) transient. In conclusion, none of the investigated beta-adrenoceptor antagonists influenced Ca(2+) sensitivity of myofibrillar tension development in human failing myocardium.</description><identifier>ISSN: 0014-2999</identifier><identifier>DOI: 10.1016/S0014-2999(01)01082-2</identifier><identifier>PMID: 11430928</identifier><language>eng</language><publisher>Netherlands</publisher><subject>Adrenergic beta-Antagonists - pharmacology ; Benzopyrans - pharmacology ; Calcium - metabolism ; Calcium - pharmacology ; Carbazoles - pharmacology ; Carvedilol ; Dose-Response Relationship, Drug ; Ethanolamines - pharmacology ; Female ; Heart Ventricles - drug effects ; Heart Ventricles - metabolism ; Humans ; In Vitro Techniques ; Male ; Metoprolol - pharmacology ; Middle Aged ; Myocardial Contraction - drug effects ; Nebivolol ; Propanolamines - pharmacology ; Ventricular Function</subject><ispartof>European journal of pharmacology, 2001-06, Vol.422 (1-3), p.175-180</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11430928$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bundkirchen, A</creatorcontrib><creatorcontrib>Brixius, K</creatorcontrib><creatorcontrib>Bölck, B</creatorcontrib><creatorcontrib>Mehlhorn, U</creatorcontrib><creatorcontrib>Bloch, W</creatorcontrib><creatorcontrib>Schwinger, R H</creatorcontrib><title>Nebivolol, carvedilol and metoprolol do not influence cardiac Ca(2+) sensitivity</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>It has been argued that some beta-adrenoceptor antagonists may directly influence myofibrillar cross-bridge interaction in cardiac skinned fiber preparations of animal models. The present study investigates the effects of nebivolol, metoprolol and carvedilol on tension development of Triton X-100 skinned fibers obtained from human failing myocardium as well as on force of contraction and intracellular Ca(2+) transient in isolated trabeculae. In skinned fiber preparations, none of the beta-adrenoceptor antagonists (10 microM) influenced Ca(2+) sensitivity of tension development or maximal Ca(2+) activated tension (DT(max)): control: EC(50) for Ca(2+): 1.28+/-0.05 microM, DT(max): 14.09+/-0.59 mN/mm(2); nebivolol: 1.36+/-0.1 microM, 14.14+/-0.95 mN/mm(2); carvedilol: 1.32+/-0.11 microM, 13.83+/-0.90 mN/mm(2); metoprolol: 1.34+/-0.14 microM, 13.72+/-0.36 mN/mm(2). Simultaneous measurement of force and Ca(2+) transient in the presence of the beta-adrenoceptor antagonists (3 microM) showed that the decrease in force of contraction was paralleled by a similar decrease in the intracellular Ca(2+) transient. In conclusion, none of the investigated beta-adrenoceptor antagonists influenced Ca(2+) sensitivity of myofibrillar tension development in human failing myocardium.</description><subject>Adrenergic beta-Antagonists - pharmacology</subject><subject>Benzopyrans - pharmacology</subject><subject>Calcium - metabolism</subject><subject>Calcium - pharmacology</subject><subject>Carbazoles - pharmacology</subject><subject>Carvedilol</subject><subject>Dose-Response Relationship, Drug</subject><subject>Ethanolamines - pharmacology</subject><subject>Female</subject><subject>Heart Ventricles - drug effects</subject><subject>Heart Ventricles - metabolism</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Male</subject><subject>Metoprolol - pharmacology</subject><subject>Middle Aged</subject><subject>Myocardial Contraction - drug effects</subject><subject>Nebivolol</subject><subject>Propanolamines - pharmacology</subject><subject>Ventricular Function</subject><issn>0014-2999</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kFtLAzEQhfOg2Fr9CUqepEVXJ8lemseyeIOigvq8JJlZiOylbnYL_fdusfp0DnM-hpnD2IWAWwEivXsHEHEktdZzEAsQsJSRPGLT__GEnYbwBQCJlskJmwgRK9ByOWVvL2T9tq3a6oY7020J_ei5aZDX1Lebbh9xbHnT9tw3ZTVQ42iPojeO52Yurxc8UBN877e-352x49JUgc4POmOfD_cf-VO0fn18zlfraCOk7CMEsE6XqNJUIQpRpmjIAmQuU1JhmZFJNBkt9dIiJkqTQxlrcNaWyUioGbv63Tue-D1Q6IvaB0dVZRpqh1BkYvw2zsQIXh7AwdaExabztel2xV8H6gfhCV2N</recordid><startdate>20010622</startdate><enddate>20010622</enddate><creator>Bundkirchen, A</creator><creator>Brixius, K</creator><creator>Bölck, B</creator><creator>Mehlhorn, U</creator><creator>Bloch, W</creator><creator>Schwinger, R H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20010622</creationdate><title>Nebivolol, carvedilol and metoprolol do not influence cardiac Ca(2+) sensitivity</title><author>Bundkirchen, A ; Brixius, K ; Bölck, B ; Mehlhorn, U ; Bloch, W ; Schwinger, R H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p122t-d00bc9fd3663dd11f6daeb007c7323df7ea59ea9298bdd539ecd2490cbbf53233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adrenergic beta-Antagonists - pharmacology</topic><topic>Benzopyrans - pharmacology</topic><topic>Calcium - metabolism</topic><topic>Calcium - pharmacology</topic><topic>Carbazoles - pharmacology</topic><topic>Carvedilol</topic><topic>Dose-Response Relationship, Drug</topic><topic>Ethanolamines - pharmacology</topic><topic>Female</topic><topic>Heart Ventricles - drug effects</topic><topic>Heart Ventricles - metabolism</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Male</topic><topic>Metoprolol - pharmacology</topic><topic>Middle Aged</topic><topic>Myocardial Contraction - drug effects</topic><topic>Nebivolol</topic><topic>Propanolamines - pharmacology</topic><topic>Ventricular Function</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bundkirchen, A</creatorcontrib><creatorcontrib>Brixius, K</creatorcontrib><creatorcontrib>Bölck, B</creatorcontrib><creatorcontrib>Mehlhorn, U</creatorcontrib><creatorcontrib>Bloch, W</creatorcontrib><creatorcontrib>Schwinger, R H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bundkirchen, A</au><au>Brixius, K</au><au>Bölck, B</au><au>Mehlhorn, U</au><au>Bloch, W</au><au>Schwinger, R H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nebivolol, carvedilol and metoprolol do not influence cardiac Ca(2+) sensitivity</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2001-06-22</date><risdate>2001</risdate><volume>422</volume><issue>1-3</issue><spage>175</spage><epage>180</epage><pages>175-180</pages><issn>0014-2999</issn><abstract>It has been argued that some beta-adrenoceptor antagonists may directly influence myofibrillar cross-bridge interaction in cardiac skinned fiber preparations of animal models. The present study investigates the effects of nebivolol, metoprolol and carvedilol on tension development of Triton X-100 skinned fibers obtained from human failing myocardium as well as on force of contraction and intracellular Ca(2+) transient in isolated trabeculae. In skinned fiber preparations, none of the beta-adrenoceptor antagonists (10 microM) influenced Ca(2+) sensitivity of tension development or maximal Ca(2+) activated tension (DT(max)): control: EC(50) for Ca(2+): 1.28+/-0.05 microM, DT(max): 14.09+/-0.59 mN/mm(2); nebivolol: 1.36+/-0.1 microM, 14.14+/-0.95 mN/mm(2); carvedilol: 1.32+/-0.11 microM, 13.83+/-0.90 mN/mm(2); metoprolol: 1.34+/-0.14 microM, 13.72+/-0.36 mN/mm(2). Simultaneous measurement of force and Ca(2+) transient in the presence of the beta-adrenoceptor antagonists (3 microM) showed that the decrease in force of contraction was paralleled by a similar decrease in the intracellular Ca(2+) transient. In conclusion, none of the investigated beta-adrenoceptor antagonists influenced Ca(2+) sensitivity of myofibrillar tension development in human failing myocardium.</abstract><cop>Netherlands</cop><pmid>11430928</pmid><doi>10.1016/S0014-2999(01)01082-2</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2999 |
ispartof | European journal of pharmacology, 2001-06, Vol.422 (1-3), p.175-180 |
issn | 0014-2999 |
language | eng |
recordid | cdi_proquest_miscellaneous_71005471 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Adrenergic beta-Antagonists - pharmacology Benzopyrans - pharmacology Calcium - metabolism Calcium - pharmacology Carbazoles - pharmacology Carvedilol Dose-Response Relationship, Drug Ethanolamines - pharmacology Female Heart Ventricles - drug effects Heart Ventricles - metabolism Humans In Vitro Techniques Male Metoprolol - pharmacology Middle Aged Myocardial Contraction - drug effects Nebivolol Propanolamines - pharmacology Ventricular Function |
title | Nebivolol, carvedilol and metoprolol do not influence cardiac Ca(2+) sensitivity |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T00%3A38%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nebivolol,%20carvedilol%20and%20metoprolol%20do%20not%20influence%20cardiac%20Ca(2+)%20sensitivity&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Bundkirchen,%20A&rft.date=2001-06-22&rft.volume=422&rft.issue=1-3&rft.spage=175&rft.epage=180&rft.pages=175-180&rft.issn=0014-2999&rft_id=info:doi/10.1016/S0014-2999(01)01082-2&rft_dat=%3Cproquest_pubme%3E71005471%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71005471&rft_id=info:pmid/11430928&rfr_iscdi=true |